Cargando…
Comparison of the effects of standard vs low‐dose prolonged‐release tacrolimus with or without ACEi/ARB on the histology and function of renal allografts
Targeting the renin‐angiotensin system and optimizing tacrolimus exposure are both postulated to improve outcomes in renal transplant recipients (RTRs) by preventing interstitial fibrosis/tubular atrophy (IF/TA). In this multicenter, prospective, open‐label controlled trial, adult de novo RTRs were...
Autores principales: | Cockfield, Sandra M., Wilson, Sam, Campbell, Patricia M., Cantarovich, Marcelo, Gangji, Azim, Houde, Isabelle, Jevnikar, Anthony M., Keough‐Ryan, Tammy M., Monroy‐Cuadros, Felix‐Mauricio, Nickerson, Peter W., Pâquet, Michel R., Ramesh Prasad, G. V., Senécal, Lynne, Shoker, Ahmed, Wolff, Jean‐Luc, Howell, John, Schwartz, Jason J., Rush, David N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590452/ https://www.ncbi.nlm.nih.gov/pubmed/30582281 http://dx.doi.org/10.1111/ajt.15225 |
Ejemplares similares
-
ACEIs and ARBs and Their Correlation with COVID-19: A Review
por: Yehualashet, Awgichew Shewasinad, et al.
Publicado: (2020) -
The role of ACEIs/ARBs in COVID-19: Friend or foe?
por: Zhou, Zhe, et al.
Publicado: (2020) -
Withdrawal of ACEIs or ARBs in hospitalised patients with COVID-19
Publicado: (2021) -
ACEI inhibitors and ARBs do not increase severity of COVID-19
Publicado: (2020) -
Outcomes in Patients with COVID-19 Infection Taking ACEI/ARB
por: Rico-Mesa, Juan Simon, et al.
Publicado: (2020)